1. Home
  2. TARS vs OSW Comparison

TARS vs OSW Comparison

Compare TARS & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • OSW
  • Stock Information
  • Founded
  • TARS 2016
  • OSW N/A
  • Country
  • TARS United States
  • OSW Bahamas
  • Employees
  • TARS N/A
  • OSW N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • OSW Hotels/Resorts
  • Sector
  • TARS Health Care
  • OSW Consumer Discretionary
  • Exchange
  • TARS Nasdaq
  • OSW Nasdaq
  • Market Cap
  • TARS 2.1B
  • OSW 2.0B
  • IPO Year
  • TARS 2020
  • OSW N/A
  • Fundamental
  • Price
  • TARS $46.52
  • OSW $19.59
  • Analyst Decision
  • TARS Strong Buy
  • OSW Strong Buy
  • Analyst Count
  • TARS 5
  • OSW 4
  • Target Price
  • TARS $54.20
  • OSW $20.75
  • AVG Volume (30 Days)
  • TARS 735.2K
  • OSW 470.2K
  • Earning Date
  • TARS 02-25-2025
  • OSW 02-26-2025
  • Dividend Yield
  • TARS N/A
  • OSW 0.41%
  • EPS Growth
  • TARS N/A
  • OSW 2284.58
  • EPS
  • TARS N/A
  • OSW 0.50
  • Revenue
  • TARS $129,621,000.00
  • OSW $872,619,000.00
  • Revenue This Year
  • TARS $917.88
  • OSW $13.42
  • Revenue Next Year
  • TARS $78.70
  • OSW $8.66
  • P/E Ratio
  • TARS N/A
  • OSW $39.42
  • Revenue Growth
  • TARS 801.96
  • OSW 13.60
  • 52 Week Low
  • TARS $20.08
  • OSW $11.98
  • 52 Week High
  • TARS $57.14
  • OSW $20.57
  • Technical
  • Relative Strength Index (RSI)
  • TARS 37.06
  • OSW 53.95
  • Support Level
  • TARS $43.61
  • OSW $18.48
  • Resistance Level
  • TARS $57.00
  • OSW $19.66
  • Average True Range (ATR)
  • TARS 2.65
  • OSW 0.47
  • MACD
  • TARS -1.27
  • OSW -0.03
  • Stochastic Oscillator
  • TARS 21.51
  • OSW 64.53

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About OSW OneSpaWorld Holdings Limited

OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts worldwide. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.

Share on Social Networks: